Inspire Medical Systems, Inc. (INSP) Stock
Key stats
- Market cap
- $1.80B
- Price / Earnings ratio
- 17.9x
- EPS (TTM)
- $3.41
- Volume
- Loading
- 52-week high
- $147.03
- 52-week low
- $38.91
Source: third-party data provider, as of November 13, 2026
Compare with INSP
Recent news

Inspire Medical Systems Q3 Earnings Call Highlights
Inspire Medical Systems Q3 Earnings Call Highlights
INSP

Inspire Medical Systems (INSP) Q3 Earnings and Revenues Beat Estimates
Inspire Medical Systems (INSP) Q3 Earnings and Revenues Beat Estimates
INSP

Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings
Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings
INSP

INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?
INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?
INSP
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 37.52
- MACD 12/26/9
- -1.61
- EMA 9 of MACD
- -0.73
- MACD histogram
- -0.88
- SMA 50
- $69.02
- Price below SMA 50
- EMA 50
- $66.56
- Price below EMA 50
- SMA 200
- $57.64
- Price above SMA 200
- EMA 200
- $67.52
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 10 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.43 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Inspire Medical Systems Q3 Earnings Call Highlights
Inspire Medical Systems Q3 Earnings Call Highlights
INSP

Inspire Medical Systems (INSP) Q3 Earnings and Revenues Beat Estimates
Inspire Medical Systems (INSP) Q3 Earnings and Revenues Beat Estimates
INSP

Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings
Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings
INSP

INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?
INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?
INSP

Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
INSP

Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
INSP

Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
INSP

3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
INSP

Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
INSP

INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
INSP
News tone: automated (AI) classification of the article's content, not a price prediction.
About Inspire Medical Systems, Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Timothy P. Herbert | Founder, Chairman, CEO & President | 1963 |
| Mr. Matthew J. Osberg | Executive VP & CFO | 1977 |
| Mr. Bryan K. Phillips J.D. | Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary | 1971 |
| Mr. Carlton W. Weatherby | Chief Strategy and Growth Officer | 1985 |
| Mr. Jason P. Kelly | Chief Operations & Innovation Officer | 1980 |
| Ms. Melissa J. Mann | Chief People Officer | 1976 |
| Mr. Ivan Lubogo | SVP of Strategic Sales | — |
| Mr. Andreas Henke | Executive VP International & MD | — |
| Mr. Joseph E. Sander | Senior Vice President of U.S. Sales | — |
| Ms. Megan Rowekamp CPA | Director of Financial Reporting | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 37.52
- MACD 12/26/9
- -1.61
- EMA 9 of MACD
- -0.73
- MACD histogram
- -0.88
- SMA 50
- $69.02
- Price below SMA 50
- EMA 50
- $66.56
- Price below EMA 50
- SMA 200
- $57.64
- Price above SMA 200
- EMA 200
- $67.52
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
10 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $60.00
- Average
- $73.10
- High
- $97.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -19.6 | +2.2 | ||||||||||
| 2022 | -7.0 | +9.6 | +5.9 | -22.8 | -18.3 | +4.8 | +10.5 | -8.4 | -4.7 | +6.9 | +25.6 | +5.1 |
| 2023 | +0.0 | +0.9 | -11.3 | +17.4 | +11.6 | +7.4 | -9.9 | -22.0 | -16.9 | -24.4 | -7.0 | +34.1 |
| 2024 | +12.3 | -17.2 | +17.0 | +15.3 | -34.9 | -9.9 | +1.7 | +23.9 | +19.2 | -6.8 | +1.1 | -1.7 |
| 2025 | +2.3 | -3.3 | -12.7 | +0.3 | -12.5 | -3.0 | -4.8 | -25.7 | -21.5 | -0.4 | +68.8 | -27.0 |
| 2026 | -17.9 | -12.2 | -20.4 | +4.7 | -27.1 | +9.2 | +10.4 | +20.6 | +12.7 | -3.8 | -7.6 |



